Actinium Pharmaceuticals to Join Stephens Biotechnology Virtual Fireside Chat

Reuters11-03
Actinium Pharmaceuticals to Join Stephens Biotechnology Virtual Fireside Chat

Actinium Pharmaceuticals Inc. will participate in the Stephens Biotechnology Virtual Fireside Chat on November 4, 2025. Chairman and CEO Sandesh Seth will join the event, and the management team will be available for one-on-one meetings with investors.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Actinium Pharmaceuticals Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: NY13691) on November 03, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment